Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors

Elizabeth C Smyth, Francesco Sclafani, David Cunningham Department of Gastrointestinal Oncology, Royal Marsden Hospital, Sutton, UK Abstract: The MET/hepatocyte growth-factor (HGF) signaling pathway plays a key role in the processes of embryogenesis, wound healing, and organ regeneration. Aberrant...

Full description

Bibliographic Details
Main Authors:	Smyth EC, Sclafani F, Cunningham D
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-06-01
Series:	OncoTargets and Therapy
Online Access:	http://www.dovepress.com/emerging-molecular-targets-in-oncology-clinical-potential-of-methepato-a17190

Similar Items

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
by: Parikh RA, et al.
Published: (2014-06-01)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
by: Young Mi Whang, et al.
Published: (2019-01-01)

MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
by: Katja Schmitz, et al.
Published: (2015-01-01)

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
by: Maria Trovato, et al.
Published: (2017-03-01)

The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
by: Marjorie Boissinot, et al.
Published: (2014-08-01)

PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells
by: Durden Donald L, et al.
Published: (2009-11-01)

Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter Factor
by: Rick V. Hay, et al.
Published: (2002-01-01)

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
by: Natalie J. Rothenberger, et al.
Published: (2017-04-01)

Editorial of Special Issue “New Aspects of the Hepatocyte Growth Factor/c-Met System”
by: Giulia Ricci
Published: (2015-06-01)

Study on Mechanism by which Hepatocyte Growth Factor Receptor c-Met Tranlocates to the Nucleus
by: Chung-Ying Tsai, et al.

The expression of hepatocyte growth factor and Met receptor signaling in proliferative and necrotizing pneumonia in swine
by: Yun-Hua Yu, et al.

Hepatocyte growth factor/scatter factor and C-met ligand-receptor in human breast cancer
by: Nagy, Janos
Published: (2000)

A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway
by: Hironori Tsujimoto, et al.
Published: (2020-07-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

Molecular Diagnostics in Clinical Oncology
by: Anna P. Sokolenko, et al.
Published: (2018-08-01)

Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care
by: Vandana K Dhingra, et al.
Published: (2015-10-01)

Improvement of Sepsis by Hepatocyte Growth Factor, an Anti-Inflammatory Regulator: Emerging Insights and Therapeutic Potential
by: Shinya Mizuno, et al.
Published: (2012-01-01)

An investigation of the role of the tyrosine kinase receptor met and its ligand Hepatocyte growth Factor in growth regulation in ovarian cancer
by: Fisher, Ann Doreen
Published: (2010)

Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells
by: Davis Rodney, et al.
Published: (2006-07-01)

The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment
by: Haiyan Fu, et al.
Published: (2021-10-01)

Molecular targets for radiation oncology in prostate cancer
by: Tao eWang, et al.
Published: (2011-07-01)

Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor
by: Takahito Hara, et al.
Published: (2020-03-01)

Small Molecules as Potential Inhibitors of the Met Tyrosine Kinase Receptor
by: Luzac, Michal Leonie
Published: (2008)

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020-10-01)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
by: Qiming Wang, et al.
Published: (2019-06-01)

Development of antibody-based c-Met inhibitors for targeted cancer therapy
by: Lee D, et al.
Published: (2015-02-01)

Clinical and biological implications of ΔNp63α, an emerging therapeutic oncological target gene
by: Choudhury, Natasha
Published: (2011)

Hepatocyte Transplantation: Clinical Experience and Potential for Future Use
by: Stephen C. Strom, et al.
Published: (2006-01-01)

Novel therapies emerging in oncology to target the TGF-β pathway
by: Byung-Gyu Kim, et al.
Published: (2021-04-01)

Hepatocyte growth factor : Molecular Mechanisms of Colorectal Cancer Metastasis
by: McCullough, Peter W.
Published: (2009)

Activation of Hepatocyte Growth Factor-Met Autocrine Loop Enhances Tumorigenicity in a Human Lung Adenocarcinoma Cell Line
by: Seung Yi, et al.
Published: (2000-05-01)

Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
by: Davidson M, et al.
Published: (2016-07-01)

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
by: Anuhya Kommalapati, et al.
Published: (2021-06-01)

Molecular and genetic aspects of oncology and infectology in Clinics
by: Mauricio Rocha-e-Silva
Published: (2012-12-01)

Comprehensive review of oncological emergencies seen in clinical practice
by: Paul Oben, et al.
Published: (2019-03-01)

Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling
by: Lee JK, et al.
Published: (2014-10-01)

Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling
by: Tong Cao, et al.
Published: (2018-08-01)

Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway.
by: Yu-Min Lin, et al.
Published: (2012-01-01)

An Emerging Role for Radiation Oncology in Precision Oncology
by: Sharad Goyal, et al.
Published: (2016-03-01)

c-MET as a potential therapeutic target and biomarker in cancer
by: J. Rafael Sierra, et al.
Published: (2011-11-01)

Cannot write session to /tmp/vufind_sessions/sess_19hroetbnmg1vhar6ne38imk61